Actively Recruiting
Impact of Medjool Date Consumption on Labor and Delivery Outcomes
Led by The Cleveland Clinic · Updated on 2026-01-23
250
Participants Needed
1
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The proposed Medjool date randomized trial will help inform clinical practice regarding the utility of Medjool date consumption for labor onset by comparing the incidence of spontaneous labor with the need for labor induction in patients who have been randomized to consume Medjool dates from 34 weeks gestation through the day after delivery day. The study will secondarily investigate the relationship between date consumption and other important labor and delivery outcomes such as length of labor, need for oxytocin, dose of oxytocin and quantitative blood loss at delivery. This study will also explore the association between Medjool date consumption, perinatal hemoglobin levels, and perinatal diet quality. Assessing dietary intake is an essential component of this study to better understand the relationship between medjool date consumption and pregnancy/labor outcomes by controlling for it as a potential confounding factor. Furthermore, assessing dietary intake will provide insight on the impact medjool date consumption has on overall maternal diet quality.
CONDITIONS
Official Title
Impact of Medjool Date Consumption on Labor and Delivery Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Singleton pregnancy less than 36 weeks 0 days gestational age
- Age 6518 years old
- Has decision-making capacity and able to provide informed consent for research participation
- Able to speak, read and understand English
- Planned delivery at a Cleveland Clinic Institution
You will not qualify if you...
- Pre-existing medical co-morbidities including hypertension, kidney disease, autoimmune conditions, diabetes
- Comorbidities of pregnancy including hypertensive disorders of pregnancy and gestational diabetes
- Abnormal genetic (aneuploidy) screening or diagnostic testing
- Patients with pregnancies complicated by major fetal anomalies
- Multifetal gestation
- Delivery at an outside institution
- Incomplete delivery data
- Planned cesarean delivery
- Planned induction of labor prior to 41 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Actively Recruiting
Research Team
E
Easha Patel, M.D.
CONTACT
S
Stacey Ehrenberg, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here